期刊文献+

伊贝沙坦对肾间质纤维的保护及治疗作用实验研究

Experimental study regarding protective and therapeutic effects of irbesartan on renal interstitial fibrosis
下载PDF
导出
摘要 目的观察伊贝沙坦对单侧输尿管梗阻大鼠肾间质中PDGF-BB介导的肾间质纤维化的影响。方法制作大鼠肾间质纤维化模型,随机分为假手术组、模型组和伊贝沙坦治疗组,术后第7、14天分别处死各组中6只大鼠,检测大鼠肾功能、尿β2-微球蛋白,用免疫组化方法测定肾组织中α-平滑肌肌动蛋白(α-SMA)和血小板衍生生长因子(PDGF-BB)蛋白表达,动态观察肾脏病理变化。结果与输尿管梗阻核型(UUO)组比较,治疗组肾间质纤维化明显减轻(P<0.05),肾间质中α-SMA、PDGF-BB表达明显减少(P<0.05)。结论伊贝沙坦可通过下调肾间质PDGF-BB表达减轻肾组织间质纤维化。 Objective To investigate the effect of irbesartan on the expression of platelet-derived growth factor-bb(PDGF-BB) and its mechanism of renal interstitial fibrosis following unilateral ureteral obstruction(UUO) in rat kidney.Methods The rat models of renal interstitial fibrosis were established, and sham-operation, irbesartan treatment and control group were set up. 6 rats of each group were killed respectively at 7、14 days after surgery. Venous blood sample was collected to measure the levels of 24-hour ureal protein. The pathological changes and expression of PDGF-BB,α-smooth muscle actin(α-SMA) in renal interstitium were observed. Results Irbesartan could significantly decrease the expression of PDGF-BB( P 〈0.05) and α-SMA( P 〈0.05) in renal interstitium.Conclusion Irbesartan may play a protective role in the kidney by down-regulating PDGF-BB and alleviating renal interstitial fibrosis following UUO.
出处 《河北医药》 CAS 2008年第4期434-435,共2页 Hebei Medical Journal
基金 石家庄市科技支撑计划项目(编号:061461373)
关键词 肾间质 纤维化 伊贝沙坦 renal interstitium fibrosis irbesartan
  • 相关文献

参考文献8

二级参考文献60

  • 1[1]Wolf G, Ziyadeh FN.Molecular mechanisms of diabetic renal hypertrophy. Kidney Int, 1999,56:393-405
  • 2[2]Wolf G. Link between angiotensin II and TGF-β in the kidney.Miner Elect rolyte Metab, 1998,24:174-180
  • 3[3]Sharma K, Ziyadeh FN.Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-β as a key mediator.Diabetes, 1995,44:1139-1146
  • 4[4]Shankland SJ, Scholey JW Ly H, et al. Expression of transforming growth factor-β1 during diabetic renal hypertrophy. Kidney Int, 1994,46:430-442
  • 5[5]Ruilope LM.Renoprotection and renin-angiotensin system blockade in diabetes mellitus. Am J Hypertensions, 1997,10:325S-331S
  • 6[6]Califf RM, Cohn JN. Cardiac protection: evolving role of angiotensin receptor blockers. AmHeartJ, 2000,139:S15-22
  • 7[7]UrataH, Strobel F, Strobel, Ganten D. Widespread tissue distribution of human chymase. J Hypertens, Supp1 1994,12:S17-S22
  • 8[1]Muchaneta-Kubara EC, el Nahas. Myofibroblast phenotypes expression in the experimental renal scarring. Nephrol Dial Transplant,1997,12:904-915.
  • 9[2]Boukhalfa G, Desemouliere A, Rondeau E, et al. Relationship between alphasmooth muscle actin expression and fibrotic changes in human kidney. Exp Nephrol, 1996,4:241-247.
  • 10[3]Zeisberg M, Strutz F, Muller GA. Role of fibroblast activation in inducing interstitial fibrosis. J Nephrol,2000,13(Suppl 3):S111-120.

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部